Minh P. Le

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.

Journal: Antimicrobial agents and chemotherapy

Published: June 10, 2026

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

Journal: Open forum infectious diseases

Published: March 27, 2026

Minimal impact of pregnancy on rilpivirine pharmacokinetics in women living with HIV.

Minimal impact of pregnancy on rilpivirine pharmacokinetics in women living with HIV.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 19, 2025

Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy.

Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy.

Journal: The Journal of infectious diseases

Published: August 15, 2025

Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysis.

Suboptimal concentrations of isavuconazole in critically ill patients treated for mold infections: a population pharmacokinetic analysis.

Journal: Expert opinion on drug metabolism & toxicology

Published: August 10, 2025

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 15, 2025

Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study - IMEA 057.

Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study - IMEA 057.

Journal: Journal of infection and public health

Published: May 08, 2025

Eravacycline as a last resort for difficult-to-treat resistant Acinetobacter baumannii infections in critically ill patients: three case reports with pharmacokinetic insights.

Eravacycline as a last resort for difficult-to-treat resistant Acinetobacter baumannii infections in critically ill patients: three case reports with pharmacokinetic insights.

Journal: JAC-antimicrobial resistance

Published: April 15, 2025

Insufficient cerebrospinal fluid penetration of tedizolid: a case report.

Insufficient cerebrospinal fluid penetration of tedizolid: a case report.

Journal: JAC-antimicrobial resistance

Published: February 18, 2025

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With HIV-1: First Results From the ANRS-MIE CARLAPOP Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 11, 2025

How to manage antivirals in critically ill patients with influenza?

How to manage antivirals in critically ill patients with influenza?

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: January 30, 2025

Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients.

Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients.

Journal: The Journal of antimicrobial chemotherapy

Published: November 18, 2024

Showing 1-12 of 78

Last Updated: 09/26/2026